526 related articles for article (PubMed ID: 17258938)
1. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
2. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
[TBL] [Abstract][Full Text] [Related]
3. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility.
Banfi E; Scialino G; Monti-Bragadin C
J Antimicrob Chemother; 2003 Nov; 52(5):796-800. PubMed ID: 14519676
[TBL] [Abstract][Full Text] [Related]
4. A whole blood bactericidal assay for tuberculosis.
Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Lu T; Drlica K
J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
Yamazaki T; Sato N; Yamashita K; Okazawa Y; Miyao H; Tanno K
Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635
[TBL] [Abstract][Full Text] [Related]
8. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
Steinbrück PW
Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
[No Abstract] [Full Text] [Related]
9. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar.
Rivoire N; Ravololonandriana P; Rasolonavalona T; Martin A; Portaels F; Ramarokoto H; Rasolofo Razanamparany V
Int J Tuberc Lung Dis; 2007 Jun; 11(6):683-8. PubMed ID: 17519102
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
[TBL] [Abstract][Full Text] [Related]
11. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.
Franzblau SG; Witzig RS; McLaughlin JC; Torres P; Madico G; Hernandez A; Degnan MT; Cook MB; Quenzer VK; Ferguson RM; Gilman RH
J Clin Microbiol; 1998 Feb; 36(2):362-6. PubMed ID: 9466742
[TBL] [Abstract][Full Text] [Related]
12. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
Pagliotto AD; Caleffi-Ferracioli KR; Lopes MA; Baldin VP; Leite CQ; Pavan FR; Scodro RB; Siqueira VL; Cardoso RF
J Microbiol Immunol Infect; 2016 Dec; 49(6):980-983. PubMed ID: 26454420
[TBL] [Abstract][Full Text] [Related]
14. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
[TBL] [Abstract][Full Text] [Related]
15. Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model.
Sarkar S; Sarkar D
J Biomol Screen; 2012 Aug; 17(7):966-73. PubMed ID: 22573731
[TBL] [Abstract][Full Text] [Related]
16. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
Tuberculosis Research Committee
Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
[TBL] [Abstract][Full Text] [Related]
17. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
18. Correlation between susceptibility of Mycobacterium tuberculosis by microtiter plate alamar blue assay and clinical outcomes.
Sungkanuparph S; Pracharktam R; Thakkinstian A; Buabut B; Kiatatchasai W
J Med Assoc Thai; 2002 Jul; 85(7):820-4. PubMed ID: 12296415
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
DeCoster DJ; Vena RM; Callister SM; Schell RF
Clin Microbiol Infect; 2005 May; 11(5):372-8. PubMed ID: 15819863
[TBL] [Abstract][Full Text] [Related]
20. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
Jadaun GP; Das R; Upadhyay P; Chauhan DS; Sharma VD; Katoch VM
Int J Antimicrob Agents; 2009 May; 33(5):483-6. PubMed ID: 19112008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
